$44 Million Earmarked for Research

Congress sets aside a large pot of pork-barrel funds for research projects in 2012, but not nearly as much as seen in pre-recession years.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, WWARBY

Pork-barrel spending continues despite a 2011 moratorium on the practice. While, the amount allotted for congressional earmarks has decreased by 80 percent since 2010, the last year the group Citizens Against Government Waste (CAGW), performed its analysis, the total amount still totals at $3.3 billion for 2012.

The portion of that pie going to research is $44 million, down from the $2.25 billion that The Chronicle of Higher Education estimated for 2008, despite the moratorium. While the decrease may have an impact of research institutions depending on that money, CAGW says that only a moratorium that is put into law permanently can prevent further transgressions.

However, a number of congress members are looking to end the moratorium next year to help grease the wheels of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development